MetaADEDB 2.0 @ LMMD
levocabastine
(ZCGOMHNNNFPNMX-YHYDXASRSA-N)
Structure
SMILES
N#CC1(CCC(CC1)N1CC[C@]([C@@H](C1)C)(C(=O)O)c1ccccc1)c1ccc(cc1)F
Type(s)
Approved; Investigational
ATC code(s)
R01AC02; S01GX02
Molecular Formula:
C26H29FN2O2
Molecular Weight:
420.519
Log P:
4.8320
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
64.33
CAS Number(s):
79449-98-2; 79516-68-0
Synonym(s)
1.
levocabastine
2.
1-(4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-4-piperidinecarboxylic acid
3.
Bilina
4.
levocabastine hydrochloride
5.
levophta
6.
livocab
7.
livostin
8.
lévophta
External Link(s)
MeSHC047340
PubChem Compound86295142
54385
BindingDB50019405
ChEBI135679
92584
CHEMBLCHEMBL1615438
DrugBankDB01106
DrugCentral1564
IUPHAR/BPS Guide to PHARMACOLOGY1586
KEGGdr:D08117
Therapeutic Target DatabaseD08SEI
ZINC586239
100089496
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal discomfortOFFSIDES
2Acid refluxOFFSIDES
3Amaurosis FugaxOFFSIDES
4AmenorrheaOFFSIDES
5AnorexiaOFFSIDES
6AnxietyOFFSIDES
7ApathyOFFSIDES
8ArthritisOFFSIDES
9AstheniaSIDER
10AsthmaOFFSIDES
11Bacterial Infections12669766CTD
12Blood sodiumOFFSIDES
13Cardioactive drug level increasedOFFSIDES
14CataractOFFSIDES
15CellulitisOFFSIDES
16Congenital mitochondrial cytopathyOFFSIDES
17DermatitisSIDER
18DiplopiaOFFSIDES
19DizzinessOFFSIDES
20DrowsinessOFFSIDES
21Drug withdrawal headacheOFFSIDES
22Economic problemOFFSIDES
23Electrocardiogram poor R-wave progressionOFFSIDES
24Emotional distressOFFSIDES
25ErythemaSIDER
26Eye RednessSIDER
27Eye painSIDER
28FatigueOFFSIDES
SIDER
29Food AllergyOFFSIDES
30FormicationOFFSIDES
31GammopathyOFFSIDES
32Gingival HyperplasiaOFFSIDES
33HeadacheSIDER
34Hyperalgesia23756650CTD
35HypometabolismOFFSIDES
36ImpetigoOFFSIDES
37Intervertebral Disc DegenerationOFFSIDES
38Joint stiffnessOFFSIDES
39LacrimationSIDER
40Muscle WeaknessOFFSIDES
41Musculoskeletal stiffnessOFFSIDES
42NasopharyngitisOFFSIDES
43NauseaSIDER
44NephrolithiasisOFFSIDES
45Nervous tensionOFFSIDES
46Neuralgia23756650CTD
47PainSIDER
48PertussisOFFSIDES
49PharyngitisSIDER
50PolyneuropathyOFFSIDES
51Pyoderma GangrenosumOFFSIDES
52Quality of life decreasedOFFSIDES
53Retinal DegenerationOFFSIDES
54Rhinitis8612114CTD
55SclerodermaOFFSIDES
56ScotomaOFFSIDES
57Skin ErosionOFFSIDES
58SomnolenceSIDER
59Spinal column stenosisOFFSIDES
60Status EpilepticusOFFSIDES
61Sudden deathOFFSIDES
62TinnitusOFFSIDES
63Visual ImpairmentSIDER
64Visual disturbanceSIDER
65VitrectomyOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.